E-CELL: software environment for whole-cell simulation.Masaru Tomita, Clyde A. Hutchison, Kazuaki Hashimoto et al.|Bioinformatics|1999Cited by 765
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Pasi A. Jänne, Kreshnik Zejnullahu et al.|Science Translational Medicine|2011Cited by 670
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced CancerToshio Shimizu, Amita Patnaik, G. Mangold et al.|Clinical Cancer Research|2012Cited by 432
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based studyKuniko Sunami, Takashi Kohno, Hitoshi Ichikawa et al.|Cancer Science|2019Cited by 375
Genomic analysis of immunity in a Urochordate and the emergence of the vertebrate immune system: “waiting for Godot”Kaoru Azumi, Masaru Nonaka, Rosaria De Santis et al.|Immunogenetics|2003Cited by 294